Mink Therapeutics Stock Market Value
| INKT Stock | USD 0.72 0.03 4.35% |
| Symbol | Mink |
Mink Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mink Therapeutics. If investors know Mink will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mink Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Return On Assets (0.97) | Return On Equity (12.39) |
The market value of Mink Therapeutics is measured differently than its book value, which is the value of Mink that is recorded on the company's balance sheet. Investors also form their own opinion of Mink Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Mink Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mink Therapeutics' market value can be influenced by many factors that don't directly affect Mink Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mink Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mink Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mink Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Mink Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mink Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mink Therapeutics.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Mink Therapeutics on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Mink Therapeutics or generate 0.0% return on investment in Mink Therapeutics over 30 days. Mink Therapeutics is related to or competes with Ikena Oncology, Eliem Therapeutics, HCW Biologics, RenovoRx, Tempest Therapeutics, Scpharmaceuticals, and Milestone Pharmaceuticals. MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commerci... More
Mink Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mink Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mink Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 12.3 | |||
| Value At Risk | (3.85) | |||
| Potential Upside | 4.05 |
Mink Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mink Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mink Therapeutics' standard deviation. In reality, there are many statistical measures that can use Mink Therapeutics historical prices to predict the future Mink Therapeutics' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | (0.36) |
Mink Therapeutics Backtested Returns
Mink Therapeutics has Sharpe Ratio of -0.0688, which conveys that the firm had a -0.0688% return per unit of risk over the last 3 months. Mink Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mink Therapeutics' Risk Adjusted Performance of (0.05), standard deviation of 2.34, and Mean Deviation of 1.79 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.5, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Mink Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Mink Therapeutics is expected to be smaller as well. At this point, Mink Therapeutics has a negative expected return of -0.16%. Please make sure to verify Mink Therapeutics' potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Mink Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.11 |
Insignificant reverse predictability
Mink Therapeutics has insignificant reverse predictability. Overlapping area represents the amount of predictability between Mink Therapeutics time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mink Therapeutics price movement. The serial correlation of -0.11 indicates that less than 11.0% of current Mink Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.11 | |
| Spearman Rank Test | -0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Mink Therapeutics lagged returns against current returns
Autocorrelation, which is Mink Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mink Therapeutics' stock expected returns. We can calculate the autocorrelation of Mink Therapeutics returns to help us make a trade decision. For example, suppose you find that Mink Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Mink Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mink Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mink Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mink Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Mink Therapeutics Lagged Returns
When evaluating Mink Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mink Therapeutics stock have on its future price. Mink Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mink Therapeutics autocorrelation shows the relationship between Mink Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Mink Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Mink Stock Analysis
When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.